A collaborative study with Harvard Medical School
Press Releases
Axio Biosolutions announces ESOP Buyback program for employees worth half a million USD
February 2022
Axio Biosolutions raises $6 million in a Series B2 equity round led by TrueScale Capital
July 2021
Axio Biosolutions receives another FDA clearance for Axiostat Patch for Vascular Bleeding Control
June 2021
Axio Biosolutions enters veterinary segment with the launch of SureKlot range of products
March 2021
Axio Biosolutions receives European CE Mark approval for its Advanced Woundcare product – MaxioCel
February 2021
Axio Biosolutions sets up Global Helpline Desk For Chronic Wound Patients
March 2020
Axio Biosolutions raises 36 crore in Series B-1 round led by Omidyar Network India
January 2020
Dr Shiladitya Sengupta From Harvard Medical School Joins Axio As Chairman Of Scientific Advisory Board
November 2019
Integrated wound-care company, Axio Biosolutions, enters Retail
November 2020
Covid-19: Axio Biosolutions launches hand sanitizers and surgical disinfectants under RESIST + brand to meet rising demand
April 2020
Axio Biosolutions Expands Facility, Becomes World’s Largest Chitosan Medical Sponge Manufacturer
April 2019
March 2019
Axio Biosolutions partners with GVK EMRI 108 for a safe Uttarayan
January 2019
Axio Biosolutions Launches Maxiocel, Cutting-Edge Innovation In Advance Wound Care
February 2019
Ratan Tata Invests In Medtech Startup Axio
January 2018
Medtech Startup Axio Biosolutions Reports Successful Results From Clinical Trial Of Axiostat Dental Haemostatic Dressing In Patients On Oral Antiplatelet Drugs
November 2018
Axiostat becomes the first wound dressing from India to get US FDA clearance
February 2018